Publications by authors named "Stephane Viau"

Claim this Profile
T
TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding.
Penka S Petrova, Natasja Nielsen Viller, Mark Wong, Xinli Pang, Gloria H Y Lin, Stephane Viau

Clin Cancer Res· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel small molecule with potent anticancer activity inhibits cell growth by modulating intracellular labile zinc homeostasis.
Mario Huesca, Lisa S Lock, Aye Aye Khine, Stéphane Viau, Robert Peralta

Mol Cancer Ther· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
11-Phenyl-[b,e]-dibenzazepine compounds: novel antitumor agents.
Raed A Al-Qawasmeh, Yoon Lee, Ming-Yu Cao, Xiaoping Gu, Stéphane Viau

Bioorg Med Chem Lett· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GTI-2040 displays cooperative anti-tumor activity when combined with interferon alpha against human renal carcinoma xenografts.
Aikaterini Vassilakos, Yoon Lee, Stéphane Viau, Ningping Feng, Hongnan Jin

Int J Oncol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-proliferative and anti-tumor effects of antisense oligonucleotide GTI-2601 targeted against human thioredoxin.
Yoon Lee, Aikaterini Vassilakos, Ningping Feng, Tina Avolio, Hongnan Jin, Stéphane Viau

Anticancer Drugs· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NC381, a novel anticancer agent, arrests the cell cycle in G0-G1 and inhibits lung tumor cell growth in vitro and in vivo.
Ming-Yu Cao, Yoon Lee, Ning-Ping Feng, Raed A Al-Qawasmeh, Stéphane Viau

J Pharmacol Exp Ther· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenovirus-mediated ribonucleotide reductase R1 gene therapy of human colon adenocarcinoma.
Ming-Yu Cao, Yoon Lee, Ning-Ping Feng, Keyong Xiong, Hongnan Jin, Stéphane Viau

Clin Cancer Res· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis